Parliamentary Search

Written question asked by Anneliese Dodds (Labour) on Tuesday, 13 December 2022, in the House of Commons. It was due for an answer on Tuesday, 20 December 2022 (named day). It was answered by Maria Caulfield (Conservative) on Tuesday, 20 December 2022 on behalf of the Department of Health and Social Care.

Hormone Replacement Therapy

Question

To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to monitor the national availability of HRT.

Answer

There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, factors including an increase in demand has led to supply issues with a limited number of products. We regularly engage with suppliers, the National Health Service and the Medicines and Healthcare products Regulatory Agency to maintain overall supply, including expediting resupply dates of disrupted HRT products.

We have issued Serious Shortage Protocols (SSPs) on HRT products to ensure an even distribution and allow alternative products to be dispensed as necessary. Since April 2022, 17 SSPs for HRT products have been issued and seven remain in place as the supply of several products affected by short term supply issues has been resolved. We regularly communicate with the NHS on shortages and discontinuations, including HRT products currently affected by supply issues and via the Specialist Pharmacy Service Medicine Supply tool.

Secondary information

Type
Written question
Reference
109778
Session
2022-23
Related items
Hormone Replacement Therapy
Wednesday, 18 January 2023
Written questions
House of Commons
Subjects
Hormone replacement therapy
Link
View this Written question on www.parliament.uk